The FDA says it has granted its first approval to an immunotherapy regimen for breast cancer
The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.
The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and chemotherapy: Tecentriq and Abraxane, respectively.
Chemotherapy is also needed to"rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader."We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said,"enabling people's own immune system to get at it."Norton said in October that"I think the expectation is, this will change the standard of care.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorGottlieb worked in the healthcare industry before joining the Food and Drug Administration as its top official during the Trump administration.
Weiterlesen »
FDA moves on vaping, drugs and food at risk with chief’s departureFDA Commissioner Scott Gottlieb was an outlier in the Trump administration, with an activist agenda touching everything from medical device regulation to youth smoking. His departure puts it all in jeopardy
Weiterlesen »
FDA allows genetically engineered 'Frankenfish' salmon to be imported to USAmericans are one step closer to seeing genetically modified salmon at their grocery stores.
Weiterlesen »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Weiterlesen »
Reynolds tobacco debuts e-cigarette commercial, tightens online vape sales to combat teen useReynolds is also tightening online sales as the FDA weighs e-cigarette regulations.
Weiterlesen »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Weiterlesen »
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
Weiterlesen »
Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDAScott Gottlieb, possibly Trump's only effective regulator, announces his departure from the FDA — but what will come of his initiatives? hiltzikm weighs in:
Weiterlesen »
FDA Commissioner Scott Gottlieb is resigning
Weiterlesen »
Biotech shares continue to fall on FDA uncertaintyThe biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from FDA chief Scott Gottlieb that he will be stepping down next month.
Weiterlesen »